Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Josephine B. Walton"'
Autor:
Julianna Blagih, Fabio Zani, Probir Chakravarty, Marc Hennequart, Steven Pilley, Sebastijan Hobor, Andreas K. Hock, Josephine B. Walton, Jennifer P. Morton, Eva Gronroos, Susan Mason, Ming Yang, Iain McNeish, Charles Swanton, Karen Blyth, Karen H. Vousden
Publikováno v:
Cell Reports, Vol 30, Iss 2, Pp 481-496.e6 (2020)
Summary: Loss of p53 function contributes to the development of many cancers. While cell-autonomous consequences of p53 mutation have been studied extensively, the role of p53 in regulating the anti-tumor immune response is still poorly understood. H
Externí odkaz:
https://doaj.org/article/9e8f02a81ba8423a9ff553a069bb7e18
Autor:
Douglas Strathdee, Dimitris Athineos, Karen Blyth, Elaine Y.L. Leung, Suzanne Dowson, David A. Stevenson, Julianna Blagih, Josephine B. Walton, Michelle Lockley, Karen H. Vousden, Malcolm Farquharson, Susan M. Mason, Clare Orange, Darren Ennis, Frances R. Balkwill, Iain A. McNeish, Laura A. Tookman
Publikováno v:
Europe PubMed Central
There is a need for transplantable murine models of ovarian high-grade serous carcinoma (HGSC) with regard to mutations in the human disease to assist investigations of the relationships between tumor genotype, chemotherapy response, and immune micro
Autor:
Daniel J. Murphy, Karen Blyth, Malcolm Farquharson, Jaeyeon Kim, Jennifer Port, Susan M. Mason, Suzanne Dowson, Seth B. Coffelt, Josephine B. Walton, Martin M. Matzuk, Iain A. McNeish, Björn Kruspig, David Stevenson
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-3 (2018)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Autor:
Oliver D. K. Maddocks, Peter D. Adams, Pavlina Spiliopoulou, Iain A. McNeish, Josephine B. Walton, Suzanne Dowson, Alex Binks
Publikováno v:
Clinical Cancer Research. 24:A37-A37
Background: Ovarian high-grade serous carcinoma (HGSC) remains a poor prognosis disease due to its late presentation and lack of “actionable” mutations to target pharmacologically. The host immune system, however, plays a pivotal role with the pr
Autor:
Stephen W.G. Tait, Melanie Weigert, Darren Ennis, Elaine Y.L. Leung, Suzanne Dowson, Xinzi Yu, Margaret Mullin, Karen Blyth, Dimitris Athineos, Iain A. McNeish, Clare Orange, Alex Binks, Josephine B. Walton
Publikováno v:
Cancer Research. 78:4379-4379
Introduction Oncolytic viruses are a promising new cancer therapy, since they can infect cancer cells, selectively multiply within them and induce direct cytotoxicity, leading to the release of mature viral particles that can infect other neighboring